Rheumatoid arthritis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nature Reviews Disease Primers

• Publication date

  2018-02-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nrdp.2018.1PMID 29417936
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disclosure of Personalized Rheumatoid Arthritis Risk Using Genetics, Biomarkers, and Lifestyle Factors to Motivate Health Behavior Improvements: A Randomized Controlled Trial

  2018cited by this paper
• Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

  2017cited by this paper
• Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

  2017cited by this paper
• Two rheumatoid arthritis–specific autoantigens correlate microbial immunity with autoimmune responses in joints

  2017cited by this paper
• Triple Therapy Versus Biologic Therapy for Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis.

  2017cited by this paper
• Synovial tissue research: a state-of-the-art review

  2017cited by this paper
• Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis

  2017cited by this paper
• Brief Report: Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria

  2017cited by this paper
• Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition

  2017cited by this paper
• Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.

  2017cited by this paper
• Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double‐Blind, Active Comparator– and Placebo‐Controlled Study

  2017cited by this paper
• Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis

  2017cited by this paper
• Severe Extraarticular Manifestations in a Community-based Cohort of Patients with Rheumatoid Arthritis: Risk Factors and Incidence in Relation to Treatment with Tumor Necrosis Factor Inhibitors

  2017cited by this paper
• The emerging safety profile of JAK inhibitors in rheumatic disease

  2017cited by this paper
• Synovial tissue research: a state-of-the-art review

  2017cited by this paper
• Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis

  2017cited by this paper
• Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions

  2017cited by this paper
• The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era: Prevention and Management.

  2017cited by this paper
• Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases

  2017cited by this paper
• Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.

  2017cited by this paper
• Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.

  2017cited by this paper
• supplement to: Baricitinib versus placebo or adalimumab in rheumatoid arthritis.

  2017cited by this paper
• Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease‐Modifying Antirheumatic Drug Treatment

  2017cited by this paper
• DNA methylation mediates genotype and smoking interaction in the development of anti-citrullinated peptide antibody-positive rheumatoid arthritis

  2017cited by this paper
• Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

  2016cited by this paper
• An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis

  2016cited by this paper
• High-specificity bioinformatics framework for epigenomic profiling of discordant twins reveals specific and shared markers for ACPA and ACPA-positive rheumatoid arthritis

  2016cited by this paper
• NSAID-induced Gastrointestinal Injury: A Focused Update for Clinicians.

  2016cited by this paper
• Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial.

  2016cited by this paper
• The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting

  2016cited by this paper
• The role of female hormonal factors in the development of rheumatoid arthritis

  2016cited by this paper
• Post‐Traumatic Stress Disorder and Risk for Incident Rheumatoid Arthritis

  2016cited by this paper
• Abdominal obesity, gender and the risk of rheumatoid arthritis – a nested case–control study

  2016cited by this paper
• Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23

  2016cited by this paper
• Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers.

  2016cited by this paper
• Impact of intensive treatment and remission on health-related quality of life in early and established rheumatoid arthritis

  2016cited by this paper
• Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.

  2016cited by this paper
• Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs

  2016cited by this paper
• Rheumatoid Arthritis and Mortality Among Women During 36 Years of Prospective Follow‐Up: Results From the Nurses’ Health Study

  2016cited by this paper
• Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis

  2016cited by this paper
• Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology

  2016cited by this paper
• Efficacy and Outcome of Rapid Access Rheumatology Consultation: An Office-based Pilot Cohort Study

  2016cited by this paper
• Elevated IgA Plasmablast Levels in Subjects at Risk of Developing Rheumatoid Arthritis

  2016cited by this paper
• Replication of Associations of Genetic Loci Outside the HLA Region With Susceptibility to Anti–Cyclic Citrullinated Peptide–Negative Rheumatoid Arthritis

  2016cited by this paper
• Differentially Methylated DNA Regions in Monozygotic Twin Pairs Discordant for Rheumatoid Arthritis: An Epigenome-Wide Study

  2016cited by this paper
• Aggregatibacter actinomycetemcomitans–induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis

  2016cited by this paper
• Joint-specific DNA methylation and transcriptome signatures in rheumatoid arthritis identify distinct pathogenic processes

  2016cited by this paper
• 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

  2016cited by this paper
• The changing landscape of biosimilars in rheumatology

  2016cited by this paper
• Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment

  2016cited by this paper
• Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis

  2016cited by this paper
• Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: A systematic literature review.

  2016cited by this paper
• Increased inflammation and disease activity among current cigarette smokers with rheumatoid arthritis: a cross-sectional analysis of US veterans.

  2016cited by this paper
• Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor

  2016cited by this paper
• Rheumatoid arthritis

  2016cited by this paper
• Chikungunya Pathogenesis: From the Clinics to the Bench.

  2016cited by this paper
• Association Between Genetic Variation in FOXO3 and Reductions in Inflammation and Disease Activity in Inflammatory Polyarthritis

  2016cited by this paper
• Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study.

  2016cited by this paper
• Baricitinib in Patients with Refractory Rheumatoid Arthritis.

  2016cited by this paper
• Baricitinib for the treatment of rheumatoid arthritis

  2016cited by this paper
• A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective

  2016cited by this paper
• Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT

  2015cited by this paper
• Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

  2015cited by this paper
• Impact of physicians’ adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial

  2015cited by this paper
• Citrullinated Autoantigens: From Diagnostic Markers to Pathogenetic Mechanisms

  2015cited by this paper
• Nested Case–Control Study of Selected Systemic Autoimmune Diseases in World Trade Center Rescue/Recovery Workers

  2015cited by this paper
• Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis.

  2015cited by this paper
• Distinctions Between Diagnostic and Classification Criteria?

  2015cited by this paper
• DNA Methylome Signature in Synoviocytes From Patients With Early Rheumatoid Arthritis Compared to Synoviocytes From Patients With Longstanding Rheumatoid Arthritis

  2015cited by this paper
• Immunoregulatory role of IL-35 in T cells of patients with rheumatoid arthritis.

  2015cited by this paper
• APLAR rheumatoid arthritis treatment recommendations

  2015cited by this paper
• Optimisation of a treat-to-target approach in rheumatoid arthritis: strategies for the 3-month time point

  2015cited by this paper
• Quality of Life and its Predictors Among Iranian Patients With Rheumatoid Arthritis: A Systematic Review

  2015cited by this paper
• Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials

  2015cited by this paper
• American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

  2015cited by this paper
• Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss

  2015cited by this paper
• Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges

  2015cited by this paper
• Occupational exposure to textile dust increases the risk of rheumatoid arthritis: results from a Malaysian population-based case–control study

  2015cited by this paper
• Capture Hi-C reveals novel candidate genes and complex long-range interactions with related autoimmune risk loci

  2015cited by this paper
• MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial

  2014cited by this paper
• Rheumatoid Factor as a Potentiator of Anti–Citrullinated Protein Antibody–Mediated Inflammation in Rheumatoid Arthritis

  2014cited by this paper
• Periodontitis: from microbial immune subversion to systemic inflammation

  2014cited by this paper
• Relative efficiencies of the 7 rheumatoid arthritis Core Data Set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents.

  2014cited by this paper
• Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial

  2014cited by this paper
• Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

  2014cited by this paper
• Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis

  2014cited by this paper
• Clinically Important Changes in Short Form 36 Health Survey Scales for Use in Rheumatoid Arthritis Clinical Trials: The Impact of Low Responsiveness

  2014cited by this paper
• Biomarkers for radiographic progression in rheumatoid arthritis.

  2014cited by this paper
• Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) Family Study: rationale and design for a randomized controlled trial evaluating rheumatoid arthritis risk education to first-degree relatives.

  2014cited by this paper
• Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial.

  2014cited by this paper
• Assessment of health-related quality of life, anxiety and depression in patients with early rheumatoid arthritis

  2014cited by this paper
• Smokeless Tobacco (Moist Snuff) Use and the Risk of Developing Rheumatoid Arthritis: Results From a Case–Control Study

  2014cited by this paper
• Gender differences in autoimmune disease.

  2014cited by this paper
• The disease formerly known as rheumatoid arthritis

  2014cited by this paper
• A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of 2 Dosing Regimens of Fostamatinib in Patients with Rheumatoid Arthritis with an Inadequate Response to a Tumor Necrosis Factor-α Antagonist

  2014cited by this paper
• Association between helplessness, disability, and disease activity with health-related quality of life among rheumatoid arthritis patients in a multiethnic Asian population

  2014cited by this paper
• Comparative Effectiveness of Anti–Tumor Necrosis Factor Drugs on Health‐Related Quality of Life Among Patients With Inflammatory Arthritis

  2014cited by this paper
• Glucocorticoid Dose Thresholds Associated With All‐Cause and Cardiovascular Mortality in Rheumatoid Arthritis

  2014cited by this paper
• Alcohol Consumption and Risk of Incident Rheumatoid Arthritis in Women: A Prospective Study

  2014cited by this paper
• IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritis-specific immune complexes containing anticitrullinated protein antibodies

  2014cited by this paper

• A near-infrared fluorescent probe with rapid-response hypochlorite for imaging rheumatoid arthritis and wound healing in vivo.

  2026cites this paper
• Naringin nanoparticles alleviate RA-ILD pulmonary fibrosis by targeting 14-3-3ζ to inhibit LYVE1+ macrophages TGF-β1 secretion

  2026cites this paper
• Pathogenic Drivers of Difficult-to-Treat Rheumatoid Arthritis: Synovium and Beyond.

  2026cites this paper
• Multidimensional effects of the Xin’an Jianpi Tongbi Formula on self-perception of patients with rheumatoid arthritis: focusing on the mediating role of systemic inflammation index

  2026cites this paper
• Associations of blood cell indices with the severity of rheumatoid arthritis: a retrospective case–control and machine learning modeling study

  2026cites this paper
• Discovery of Novel NMR-Based Biomarkers and Interpretable Machine Learning Models for Risk Prediction of Rheumatoid Arthritis

  2026cites this paper
• Advanced molecularly imprinted polymers for disease treatment via targeting molecular abnormalities: Promises and challenges

  2026cites this paper
• HLA DRB1*01 and *04 Predisposition to Rheumatoid Arthritis and Polymorphisms of the SLCO1B1, MTHFR and PNPLA3 Genes Are Not Associated with Fatty Liver and Hepatotoxicity.

  2026cites this paper
• Blumea balsamifera Alleviates Rheumatoid Arthritis by Suppressing Synovial Inflammation via the PI3K/AKT Signaling Pathway: From Chemical Profiling to Molecular Mechanism

  2026cites this paper
• Roles of immune cell metabolism in rheumatoid arthritis.

  2026cites this paper
• Neutrophils as critical orchestrators of chronic inflammation

  2026influential citation
• Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA).

  2026cites this paper
• TWEAK receptor (Fn14) exacerbates TNF-α-induced inflammation in rheumatoid arthritis synovial fibroblasts and influences response to anti-TNF-α therapy

  2026cites this paper
• The NF-κB-inducing kinase: a central regulator of immunity and autoimmune diseases

  2026cites this paper
• Circulating fibroblasts and neutrophils co-expressing CDH11+ and chemokine receptors in rheumatoid and psoriatic arthritis: a shared mechanism of ‘arthritis spreading’?

  2026cites this paper
• The rheumatoid arthritis citrullinome is enriched in antigenic complement proteins

  2026cites this paper
• Artemisiaherba alba Outperforms Indomethacin with Multitarget Efficacy and Safety in CFA Arthritic Model.

  2026cites this paper
• Is Seronegative Rheumatoid Arthritis Far From Being a Benign Subtype of Rheumatoid Arthritis? A Retrospective Comparative Study of Seronegative Rheumatoid Arthritis and Seropositive Rheumatoid Arthritis

  2026cites this paper
• Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity: a randomised, controlled trial (SORAIRO trial).

  2026cites this paper
• Targeted delivery of curcumin based on nanocarriers: potential therapeutic strategies for noninfectious arthritis.

  2026cites this paper
• Menstrual characteristics among rheumatoid arthritis patients receiving Janus kinase inhibitor, biologics, or methotrexate.

  2026cites this paper
• Lymph nodes-targeted nano-prodrug for precise B cell immunoregulation to prevent collagen-induced arthritis.

  2026cites this paper
• Biomarkers in Rheumatoid Arthritis: From Traditional Serology to Precision Medicine Integration

  2026influential citation
• The role of the lymphatic system in musculoskeletal system health and disease: research progress and future directions

  2026cites this paper
• WISP-3 facilitates CCL4-dependent monocyte migration and M1 polarization in rheumatoid arthritis by inhibiting miR-6894-5p

  2026cites this paper
• Assessment of drug levels as a biomarker in rheumatoid arthritis

  2026cites this paper
• Oral ginger-derived extracellular vesicles ameliorate arthritis via anti-inflammatory actions of microRNA-149 and 6-gingerol

  2026cites this paper
• Investigation the autoantibodies, IL-17 and IL-22 in rheumatoid arthritis patients

  2026cites this paper
• Quality by Design-Driven Approach to Develop a Nanocarrier-Based Sulfasalazine Topical System for Rheumatoid Arthritis Management.

  2026cites this paper
• T-cell-targeted fusogenic nanovesicles generate CAR-T cells in vivo for rheumatoid arthritis therapy

  2026cites this paper
• Stripping cell-free DNA from its immune complex is essential for inflammation control using DNase I.

  2026cites this paper
• Site- and Size-Controlled PEGylation Modulates Biointerfaces and Immunoregulatory Functions of Bifunctional Peptides in an Autoimmune Disease Model.

  2026cites this paper
• Insights on In Silico Approaches for Identifying Potential Allosteric Modulators From the Essential Oil of Pelargonium graveolens for TNF‐α in the Management of Rheumatoid Arthritis

  2026cites this paper
• The role of remote outpatient monitoring in the rheumatoid arthritis activity control

  2026cites this paper
• Sequential Phialemoniopsis curvata and Botryosphaeria dothidea infections over three years in bilateral lower limbs of a rheumatoid arthritis patient: a case-based review

  2026cites this paper
• Mitochondrial transplantation ameliorates rheumatoid arthritis by targeting abnormal CGAS-STING1 signaling activation, autophagosome accumulation, and necroptosis.

  2026cites this paper
• Therapeutic Nanozymes in Rheumatoid Arthritis Treatment Through Disease Stage-Oriented Strategies

  2026cites this paper
• [Predictors of ineffective therapy in patients with rheumatoid arthritis requiring bDMARDs/JAKi switching: data from a single-center prospective study].

  2026cites this paper
• Unveiling potential diagnostic biomarkers for rheumatoid arthritis through integrated gene expression analysis

  2026cites this paper
• Comparison of agreement between three classification criteria for early rheumatoid arthritis (ERA) in Shanxi Province of China.

  2026cites this paper
• Performance of an artificial intelligence model compared with multiple human experts in scoring synovitis and osteophyte severity on joint ultrasound images

  2026cites this paper
• TASTY trial: protocol for a study on the triad of nutrition, intestinal microbiota and rheumatoid arthritis

  2025cites this paper
• Metabolic Reprogramming in Stromal and Immune Cells in Rheumatoid Arthritis and Osteoarthritis: Therapeutic Possibilities

  2025cites this paper
• Therapeutic effect of miR-30b-5p-loaded lentivirus on experimental autoimmune uveitis via inhibiting Notch signaling activation

  2025cites this paper
• Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress

  2025cites this paper
• Neutrophils: a Central Point of Interaction Between Immune Cells and Nonimmune Cells in Rheumatoid Arthritis

  2025cites this paper
• Primary non-response in inflammatory arthritis treated with biologics and targeted therapies in daily clinical practice

  2025cites this paper
• Preparation, Characterization and Ex vivo Evaluation of Trigonellafoenum-gracium seeds extract-loaded Transferosomal gel for the Treatment of Rheumatoid Arthritis

  2025cites this paper
• Proteasome Inhibitors: Potential in Rheumatoid Arthritis Therapy?

  2025cites this paper
• Healthy and premature aging of monocytes and macrophages

  2025cites this paper
• Rheumatoid arthritis and psoriatic arthritis: is the disease impact different? A large matching study at diagnosis and after 1 year of treatment

  2025cites this paper
• Comparison of anti-inflammatory and anti-angiogenic effects of JAK inhibitors in IL-6 and TNFα-stimulated fibroblast-like synoviocytes derived from patients with RA

  2025cites this paper
• A Multifunctional Enzyme Cascade Catalytic Nanoplatform for Effective Synergistic Therapy of Rheumatoid Arthritis

  2025cites this paper
• Mesenchymal stem cells or extracellular vesicles in the choice of rheumatoid arthritis treatment

  2025cites this paper
• Resolution of inflammation during rheumatoid arthritis

  2025cites this paper
• Formulation of Nanogel Loaded with Lantana montevidensis-Incorporated Silver Nanoparticles: A Bio-Inspired Approach to Rheumatoid Arthritis Therapy

  2025cites this paper
• Comparing Moxibustion Strategies in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis

  2025cites this paper
• Phytochemical profile of Pereskia aculeata Miller and its bioactive constituents for treating rheumatoid arthritis' s inflammation via inhibiting COX-2 target

  2025cites this paper
• Novel regulation mechanism of histone methyltransferase SMYD5 in rheumatoid arthritis

  2025cites this paper
• A diagnostic model for assessing the risk of osteoporosis in patients with rheumatoid arthritis based on bone turnover markers

  2025cites this paper
• From genetic variants to therapeutic targets: insights into understanding rheumatoid arthritis

  2025cites this paper
• Newly-diagnosed rheumatoid arthritis patients have elevated levels of plasma extracellular vesicles with protein cargo altered towards inflammatory processes

  2025cites this paper
• Trajectories of health status and their association with rheumatoid arthritis risk: insights from a national prospective cohort study

  2025cites this paper
• Genetic or therapeutic disruption of the Reelin/Apoer2 signaling pathway improves inflammatory arthritis outcomes

  2025cites this paper
• Mendelian randomization and mediation analysis reveal the role of immune cell subsets in the causal pathways between blood cell perturbation responses and rheumatoid arthritis

  2025cites this paper
• Cartilage-Targeting Fluorophores for Early Detection of Arthritis in the NIR-II Window.

  2025cites this paper
• A Caspase-3 responsive nanoemulsion for targeted treatment of rheumatoid arthritis through dual modulation of inflammation and mitochondrial dysfunction.

  2025cites this paper
• Health professionals’ experiences delivering an Interdisciplinary Nurse-coordinated SELf-MAnagement intervention for patients with inflammatory arthritis

  2025cites this paper
• Inverse association between serum Klotho levels and rheumatoid arthritis risk: Insights from the NHANES database

  2025cites this paper
• FCGR1A(CD64) expression on monocyte subsets and FIL1Z(IL-37) serum level as biomarkers of rheumatoid arthritis activity: A case controlled study and in silico analysis.

  2025cites this paper
• Predicting rheumatoid arthritis progression from seronegative undifferentiated arthritis using machine learning: a deep learning model trained on the KURAMA cohort and externally validated with the ANSWER cohort

  2025cites this paper
• Acquired Hemophilia Associated with Rheumatoid Arthritis: A Case Report and Review of the Literature

  2025cites this paper
• Emodin mitigates rheumatoid arthritis through direct binding to TNF-α

  2025cites this paper
• Human nasal turbinate stem cells with specific gene signatures (HAS2, CXCL1, KRTAP1-5, GSTT2B, and C4B) attenuate rheumatoid arthritis

  2025cites this paper
• Biomimetic Nanoparticles Inhibit the HIF-1α/iNOS/NLRP3 Pathway to Alleviate Rheumatoid Arthritis.

  2025cites this paper
• A 10-year knowledge mapping of T cells in rheumatoid arthritis: A bibliometric analysis

  2025cites this paper
• Ultrasound-mediated nanomaterials for the treatment of inflammatory diseases

  2025cites this paper
• The association between genetic characteristics and treatment failure when switching from biologic disease-modifying antirheumatic drugs/Janus kinase inhibitors in patients with rheumatoid arthritis

  2025cites this paper
• Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update.

  2025cites this paper
• Exploring drug utilization patterns, healthcare resource utilization, and epidemiology of rheumatoid arthritis in Colombia: a retrospective claims database study

  2025cites this paper
• Cytotoxic Response of CD4+ T Cells Orchestrated by SLAMF4 in Rheumatoid Arthritis

  2025cites this paper
• Circulating cell-free DNA as a potential biomarker for prediction of disease activity and prognosis among Egyptian rheumatoid arthritis patients

  2025cites this paper
• Work in the picture? The reporting of and effects on work outcomes in exercise therapy trials in people with rheumatoid arthritis or axial spondyloarthritis: a systematic review

  2025cites this paper
• Rheumatoid arthritis and risk of hearing impairment: A genetic correlation and bidirectional Mendelian randomization study

  2025cites this paper
• Omentin-1 modulates interleukin expression and macrophage polarization: Implications for rheumatoid arthritis therapy.

  2025cites this paper
• CX3CR1+ age-associated CD4+ T cells contribute to synovial inflammation in late-onset rheumatoid arthritis

  2025cites this paper
• A self-management intervention for newly diagnosed with inflammatory arthritis: a randomized controlled feasibility and fidelity study

  2025cites this paper
• A review on the epidemiology of rheumatoid arthritis: An update and trends from current literature.

  2025cites this paper
• Increased macrophage migration inhibitory factor is associated with inflammation in patients with rheumatoid arthritis

  2025cites this paper
• Gender differences in illness acceptance and coping strategies among patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis: a cross-sectional survey study

  2025cites this paper
• Microneedle Assisted Melittin‐Chondroitin Sulfate Administration for the Transdermal Therapy of Rheumatoid Arthritis

  2025cites this paper
• Perspectives of Exosomal ncRNAs in the Treatment of Bone Metabolic Diseases: Focusing on Osteoporosis, Osteoarthritis, and Rheumatoid Arthritis.

  2025cites this paper
• Rheumatoid Factor: Diagnostic and Prognostic Performance and Therapeutic Implications in Rheumatoid Arthritis

  2025cites this paper
• Probing the synovium-brain axis.

  2025cites this paper
• Single cell immunoprofile of synovial fluid in rheumatoid arthritis with TNF/JAK inhibitor treatment

  2025cites this paper
• Interdisciplinary integration strategy reveals the anti-inflammatory efficacy and potential mechanism of Jianpi Qingre Tongluo prescription in rheumatoid arthritis.

  2025cites this paper
• A sensitive fluorescent probe for monitoring hypochlorous acid levels in rheumatoid arthritis.

  2025cites this paper
• Pharmacokinetics of the systemic application of hyaluronic acid for joint arthritis treatment.

  2025cites this paper
• Modified expression of JAK-STAT pathway genes in an in vivo rheumatoid arthritis model: A preclinical study to explore genetic insights.

  2025cites this paper
• The Role of mRNA Modifications in Bone Diseases

  2025cites this paper